scispace - formally typeset
N

N. Charlotte Onland-Moret

Researcher at Utrecht University

Publications -  169
Citations -  17871

N. Charlotte Onland-Moret is an academic researcher from Utrecht University. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Genome-wide association study. The author has an hindex of 47, co-authored 149 publications receiving 15432 citations. Previous affiliations of N. Charlotte Onland-Moret include Oklahoma State University Center for Health Sciences & Aarhus University.

Papers
More filters
Journal ArticleDOI

Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort.

TL;DR: This study did not provide evidence that acrylamide intake, based on food intake questionnaires, was associated with risk for EOC in EPIC, and additional studies with more reliable estimates of exposure based on biomarkers may be needed.
Journal ArticleDOI

A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk

Valéria Troncoso Baltar, +56 more
TL;DR: The results show that in the investigation of the involvement of the OCM, the folate cycle and immune system in lung carcinogenesis, it is important to consider complex pathways rather than the effects of single vitamins or nutrients.
Journal ArticleDOI

Dietary fat intake and risk of epithelial ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

Melissa A. Merritt, +50 more
- 01 Oct 2014 - 
TL;DR: This study does not support an etiological role for total fat intake in relation to EOC risk; however, based on observations of a positive association between intake of polyunsaturated fat and invasive E OC risk, this fat subtype warrants further investigation to determine its potential role in EOC development.

Discovery of common and rare genetic risk variants for colorectal cancer

Jeroen R. Huyghe, +198 more
TL;DR: The authors in this article performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls.
Journal ArticleDOI

Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.

TL;DR: The added value of these selected AAbs as markers for ovarian cancer beyond CA125 for early detection is limited, and combined logistic regression scores of AAbs and CA125 did not improve detection sensitivity at equal level of specificity.